Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review

SIMPLE SUMMARY: Urothelial carcinoma is a malignancy that originates in the genitourinary tract. It is a heterogeneous disease that can present at different stages, and the treatment options vary in efficacy. Advances in immunotherapy stimulated adoption in urothelial carcinoma, and published trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Walia, Arman S., Sweis, Randy F., Agarwal, Piyush K., Kader, Andrew K., Modi, Parth K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750958/
https://www.ncbi.nlm.nih.gov/pubmed/35008237
http://dx.doi.org/10.3390/cancers14010073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750958/
https://www.ncbi.nlm.nih.gov/pubmed/35008237
http://dx.doi.org/10.3390/cancers14010073

Ejemplares similares